Dr. Reddy's Labs Files 6-K, Reports as Foreign Issuer

Ticker: RDY · Form: 6-K · Filed: Sep 26, 2024 · CIK: 1135951

Sentiment: neutral

Topics: sec-filing, foreign-issuer, disclosure

TL;DR

DRL filed a 6-K, confirming 20-F reporting. Standard foreign issuer update.

AI Summary

Dr. Reddy's Laboratories Limited filed a Form 6-K on September 26, 2024, to report information as a foreign private issuer. The filing indicates the company is submitting its annual reports under Form 20-F. The company is based in Hyderabad, India, and operates in the Pharmaceutical Preparations industry.

Why It Matters

This filing is a routine disclosure for foreign private issuers, confirming their reporting status and providing basic company information to the SEC and investors.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new material financial or operational information.

Key Players & Entities

FAQ

What type of filing is this Form 6-K?

This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

Which annual report form does Dr. Reddy's Laboratories Limited typically file?

Dr. Reddy's Laboratories Limited indicates it files annual reports under cover of Form 20-F.

Where is Dr. Reddy's Laboratories Limited headquartered?

The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.

What is the SIC code for Dr. Reddy's Laboratories Limited?

The Standard Industrial Classification code for Dr. Reddy's Laboratories Limited is 2834, which corresponds to Pharmaceutical Preparations.

When was this Form 6-K filed?

This Form 6-K was filed on September 26, 2024.

Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-09-26 07:37:02

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 26, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing